P2‐012: Phase 1 Development of ALZ‐801, a Novel Beta Amyloid Anti‐Aggregation Prodrug of Tramiprosate with Improved Drug Properties, Supporting Bridging to The Phase 3 Program. (1st July 2016) - Hey, John; Abushakra, Susan; Power, Aidan; Yu, Jeremy; Versavel, Mark; Tolar, Martin